Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
Carolina Mendonça Gorgulho, Graziela Gorete Romagnoli, Rosh Bharthi, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 838
The hallmarks of cancer are also the hallmarks of wound healing
Lucy MacCarthy‐Morrogh, Paul Martin
Science Signaling (2020) Vol. 13, Iss. 648
Open Access | Times Cited: 149
Low-grade Chronic Inflammation: A Shared Mechanism for Chronic Diseases
Mariana Cifuentes, Hugo Verdejo, Pablo Castro, et al.
Physiology (2024) Vol. 40, Iss. 1, pp. 000-000
Closed Access | Times Cited: 9
Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells
Sho Hangai, Takeshi Kawamura, Yoshitaka Kimura, et al.
Nature Immunology (2021) Vol. 22, Iss. 8, pp. 947-957
Closed Access | Times Cited: 55
Alarmins in autoimmune diseases
Maria Giovanna Danieli, Eleonora Antonelli, Mario Andrea Piga, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 9, pp. 103142-103142
Closed Access | Times Cited: 34
High Mobility Group Box 1 in Human Cancer
Bernardo L. Rapoport, Helen C. Steel, Annette J. Theron, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1664-1664
Open Access | Times Cited: 49
The Impact of Radiation Therapy on Innate and Adaptive Tumor Immunity
Andrew Brandmaier, Silvia C. Formenti
Seminars in Radiation Oncology (2020) Vol. 30, Iss. 2, pp. 139-144
Closed Access | Times Cited: 46
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa
Dimitra Kiritsi, Kathrin Dieter, Elke Niebergall‐Roth, et al.
JCI Insight (2021) Vol. 6, Iss. 22
Open Access | Times Cited: 35
Potential neurotoxic activity of diverse molecules released by microglia
Ivan A. Lindhout, Taryn E. Murray, Christy M. Richards, et al.
Neurochemistry International (2021) Vol. 148, pp. 105117-105117
Closed Access | Times Cited: 34
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Ruochan Chen, Ju Zou, Rui Kang, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 7-9, pp. 569-590
Closed Access | Times Cited: 14
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
Shuiling Jin, Zhenzhen Yang, Xin Hao, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery
Simona Isabelle Stoica, Coralia Bleoţu, Vlad Ciobanu, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 481-481
Open Access | Times Cited: 19
The Cellular Senescence Factor Extracellular HMGB1 Directly Inhibits Oligodendrocyte Progenitor Cell Differentiation and Impairs CNS Remyelination
Megan E. Rouillard, Jingwen Hu, Pearl A. Sutter, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 19
<p>HMGB1/CXCL12-Mediated Immunity and Th17 Cells Might Underlie Highly Suspected Autoimmune Epilepsy in Elderly Individuals</p>
Yuxiang Han, Liling Yang, Xiaoyun Liu, et al.
Neuropsychiatric Disease and Treatment (2020) Vol. Volume 16, pp. 1285-1293
Open Access | Times Cited: 28
Immunogenic Cell Death and Immunomodulatory Effects of Cabozantinib
Fabio Scirocchi, Chiara Napoletano, Angelica Pace, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
Targeting Chromosomal Architectural HMGB Proteins Could Be the Next Frontier in Cancer Therapy
Anirban Mukherjee, Karen M. Vásquez
Cancer Research (2020) Vol. 80, Iss. 11, pp. 2075-2082
Open Access | Times Cited: 26
<p>HMGB1 in Radiotherapy: A Two Headed Signal Regulating Tumor Radiosensitivity and Immunity</p>
Yin Liao, Shuya Liu, Shaozhi Fu, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 6859-6871
Open Access | Times Cited: 25
Progress in Assays of HMGB1 Levels in Human Plasma—The Potential Prognostic Value in COVID-19
Michal Štros, Eva Polanská, Tereza Hlaváčová, et al.
Biomolecules (2022) Vol. 12, Iss. 4, pp. 544-544
Open Access | Times Cited: 14
Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials
Wenjie Xu, Yuxiang Zheng, Zizheng Suo, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 14
Platelet Phagocytosis via P‐selectin Glycoprotein Ligand 1 and Accumulation of Microparticles in Systemic Sclerosis
Angelo A. Manfredi, Giuseppe A. Ramirez, Cosmo Godino, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 318-328
Closed Access | Times Cited: 20
Neutrophil Extracellular Traps: Inflammation and Biomaterial Preconditioning for Tissue Engineering
Allison E. Fetz, Gary L. Bowlin
Tissue Engineering Part B Reviews (2021) Vol. 28, Iss. 2, pp. 437-450
Closed Access | Times Cited: 18
Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled
Mohini Agarwal, Manish Kumar, Rajiv Pathak, et al.
International review of cell and molecular biology (2024), pp. 227-261
Closed Access | Times Cited: 2
Role of microRNA‑129 in cancer and non‑cancerous diseases (Review)
Bingpeng Deng, Xuan Tang, Yong Wang
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 3
Open Access | Times Cited: 17
Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse
Christine Gaboriaud, Marie Lorvellec, Véronique Rossi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Dysregulation of the mevalonate pathway during SARS‐CoV‐2 infection: An in silico study
Juan Luis Gomez Marti, Alan Wells, Adam Brufsky
Journal of Medical Virology (2020) Vol. 93, Iss. 4, pp. 2396-2405
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top